Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy subjects - ScienceDirect
Madopar (co-beneldopa): for treatment of Parkinson's disease symptoms
To Mr. Hassan Rouhani: Parkinson's Medicine; Sanctioned or Hoarded!
A comparison of the effects of controlled-release levodopa (Madopar CR) with conventional levodopa in late Parkinson's disease. - Abstract - Europe PMC
Roche | Madopar (levodopa benserazide)
Madopar 0.250 mg. 100 capsules
Pharmaceutics | Free Full-Text | 3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy
Madopar (levodopa, benserazide ) , also known as: Prolopa CR